“…This results from the predominant localization of TβR‐I and TβR‐II in lipid rafts/caveolae in these cells [Ren et al, ]. We hypothesize that high‐level accumulation (10–2,000‐fold normal) of 7‐DHC, which varies in severity in SLOS patients and SLOS tissues, results in lipid raft/caveolae dysfunction, turnover, and down‐regulation of the many resident membrane proteins in lipid rafts/caveolae, including TGF‐β receptors [Huang and Huang, ; Chen et al, , , , 2011], neurotrophin receptors [Sebastião et al, ; Zhang et al, ; Gou‐Fàbregas et al, ], G protein‐coupled receptors (GPCRs) (neurological receptors) [Björk and Svenningsson, ], ion channels [Jaffrès et al, ], receptor protein kinases (RTKs) (e.g., growth factor receptors) [Basu et al, ] and growth hormone receptor [Yang et al, ]. Down‐regulation of these important membrane proteins in tissues during embryonic development may result in prenatal and postnatal growth retardation, microcephaly, intellectual disability, multiple external malformations (e.g., cleft palate), internal anomalies, and mental retardation characteristic of SLOS.…”